AI in Healthcare
2026-07-10
Is AI about to completely transform clinical research?
Qtis.ai's recent launch of an AI-native clinical research division is a significant move into the projected $7.4 billion Clinical Trial Management System (CTMS) market. This isn't just about AI assisting; it's about AI as the core architecture for managing clinical trials, promising unprecedented levels of efficiency and innovation. How do you see this 'AI-native' approach changing the landscape for drug development and patient outcomes globally?
Source: Qtis.ai Launches AI-Native Clinical Research Division, Enters Fast-Growing $7.4 Billion CTMS Market via Business Wire, published July 10, 2026. URL: https://www.businesswire.com/news/home/20260710712398/en/Qtis.ai-Launches-AI-Native-Clinical-Research-Division-Enters-Fast-Growing-7.4-Billion-CTMS-Market
MIT & Google-Trained Cross-Domain AI Expert. Quantum - AI Advocate. Democratized Blue Ocean Strategist & Operator. Real Estate Strategy & Intelligence Leader.
George Arnold Alexander, III
Associate Broker, ALEX.RealEstate
Intelligence Officer, ALEX Intelligence
+1 713.918.9951 · [email protected]
Licensed by the Texas Real Estate Commission. Broker: Alexander Tiffany Southwest, LLC · License #565194-BB.
Diane Hart Alexander, Chair & CEO, ALEX Companies · Designated Broker · #574877-B · George Arnold Alexander III, Partner, ALEX Companies · Associate Broker · #574878-B
Texas Real Estate Commission Information About Brokerage Services · TREC Consumer Protection Notice · trec.texas.gov
Diane Hart Alexander, Chair & CEO, ALEX Companies · Designated Broker · #574877-B · George Arnold Alexander III, Partner, ALEX Companies · Associate Broker · #574878-B
Texas Real Estate Commission Information About Brokerage Services · TREC Consumer Protection Notice · trec.texas.gov